Eiko Ozono

Molecular and cellular biologist with expertise in cell cycle regulation, oncology signalling, oncology biomarker validation, cell culture & cell-based assays, high-throughput screening and CRISPR/siRNA-based functional genomics. 
Experienced in leading cross-functional projects, mentoring junior scientists, and collaborating with a pharma partner in oncology drug discovery projects. Bringing expertise in cancer cell biology and collaborative leadership to advance drug discovery programmes/ translational research.